A word from PCNSW

20.12.2019

This month, the Pharmacy Council of NSW published a notice regarding compounding pharmacies producing medicines for other pharmacies.

Perhaps it was in response to our recent advertorial in Australian Pharmacist, which can be found here:

More pharmacies are turning to compounding, but what is the true cost of business?

The unedited text from PCNSW is below:

Are you a compounding pharmacy who compounds for other stores in your banner group? Or provide compounded medication to other colleagues who do not offer a compounding service at their store but provide a “referral “service?

Both compounding pharmacists and “referral” pharmacists are reminded of their legislative obligations when entering into the provision of this type of third party service.

Recently there has been an increase in the number of complaints involving compounding pharmacists, some of which have been related to indirect supply of compounded products.

Compounding pharmacists are reminded that they must have the original prescription before the medication is supplied to the patient and the “referral” pharmacist is reminded that under no circumstances are they to relabel the compounded product, or take payment for the product.

Patients must be aware of who has prepared their medication, holding their medication records, and taking payment for the prescription.

The compounding pharmacist is responsible for contacting the patient in order to conduct a risk assessment and should provide counselling about appropriate use of the product.

Under no circumstances should compounding pharmacists provide large quantities of compounded product to be dispensed and labelled in a non-compounding store. This is in direct breach of the Therapeutic Goods Act 1989.

We are pleased to say that ACPHARM Compounding Services absolutely ticks all of these boxes, and will continue to do so to ensure the utmost compliance to state and federal regulations, protecting both your business and securing your patient’s safety.